Skip to main content

Table 2 Clinical condition of patients

From: Current utilization and influencing factors of complementary and alternative medicine among children with neuropsychiatric disease: a cross-sectional survey in Korea

Variable

Overall

CAM

P value

Current user (with or without other rehabilitation therapies)

Non-user with other rehabilitation therapies

Non-user without other rehabilitation therapies

Primary Diagnosis

     

 Epilepsy

389 (67.3)

85 (77.3)

101 (50.5)

203 (75.7)

<0.0001

 CP

56 (9.7)

9 (8.2)

41 (20.5)

6 (2.3)

 

 Developmental disordera

51 (8.8)

6 (5.5)

27 (13.5)

18 (6.7)

 

 ADHD

43 (7.4)

7 (6.4)

11 (5.5)

25 (9.3)

 

 Others

39 (6.7)

3 (2.7)

20 (10.0)

16 (6.0)

 

Disease Duration (mos)

     

 Mean ± SD

62.1 ± 47.6

65.5 ± 43.9ab

68.3 ± 46.5a

55.5 ± 49.4b

0.015

 Median (range)

48 (0–229)

57 (1–211)

55 (0–229)

38 (0–226)

 

Disease Duration

     

  < 48 months

137 (33.9)

20 (25.6)

37 (24.2)

80 (46.2)

<0.0001

  ≥ 48 months

267 (66.1)

58 (74.4)

116 (75.8)

93 (53.8)

 

Having Health Problems

     

 Yes

341 (59.0)

67 (60.9)

132 (66.0)

142 (53.0)

0.016

 No

237 (41.0)

43 (39.1)

68 (34.0)

126 (47.0)

 

Number of Health Problems

     

 Mean ± SD

0.8 ± 0.9

0.9 ± 0.9ab

0.9 ± 0.9a

0.7 ± 0.8b

0.007

 Median (range)

1 (0–5)

1 (0–4)

1 (0–5)

1 (0–4)

 

Health Problems

     

 Atopic dermatitis

60 (10.4)

10 (9.1)

20 (10.0)

30 (11.2)

0.81

 Allergic rhinitis

103 (17.8)

21 (19.1)

27 (13.5)

55 (20.5)

0.14

 Asthma

19 (3.3)

1 (0.9)

9 (4.5)

9 (3.4)

0.34

 Dyspepsia

40 (0.9)

8 (7.3)

16 (8.0)

16 (6.0)

0.68

 Growth retardation

86 (14.9)

22 (20.0)

45 (22.5)

19 (7.7)

<0.0001

 Enuresis

13 (2.2)

2 (1.8)

7 (3.5)

4 (1.5)

0.33

 Frequent URI

125 (21.6)

30 (27.3)

51 (25.5)

44 (16.4)

0.017

 Others

23 (4.0)

3 (2.7)

12 (6.0)

8 (3.0)

0.19

  1. aDevelopmental disorder other than CP